Korro Bio, Inc. (KRRO) Live Share Price, Invest From India

Korro Bio, Inc. Stock Performance

as on May 14, 2026 at 4:14 am IST

Day's Low
Day's High
$10.93
Day's Price Range
$11.31
$11.05
1.09%
Downside
2.35%
Upside
52 Week's Low
52 Week's High
$5.20
52-Week Price Range
$55.89
$11.05
52.90%
Downside
405.79%
Upside

Korro Bio, Inc. share price movements today

Previous Close: $11.22
Open: $11.29
Volume: 86.6K
Day's Low - High: $10.93 - $11.31
52 Week Low - High: $5.20 - $55.89

Korro Bio, Inc. Historical Returns

1 Month Return: -18.04 %
3 Month Return: + 0.45 %
1 Year Return: -27.85 %
3 Year Return: 0 %
5 Year Return: 0 %

Korro Bio, Inc. Stock Fundamentals & Key Indicators

Check Korro Bio, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$165.3M

EPS (TTM)

-5.0929

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-79.3M

Revenue (TTM)

3.8M

Profit Margin

0.00%

Return On Equity TTM

-87.78%

Korro Bio, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Korro Bio, Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Korro Bio, Inc.	BUY	$165.3M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$38.0B	119.7%	71.39	12.55%
BeiGene, Ltd.	NA	$32.7B	NA	71.44	8.94%
Vertex Pharmaceuticals Inc	BUY	$110.4B	109.14%	25.84	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.7B	39.88%	17.39	29.65%

Stock Returns calculator for Korro Bio, Inc. Stock including INR - Dollar returns

The Korro Bio, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Korro Bio, Inc. investment value today

Current value as on today

₹79,753

Returns

-₹20,247

(-20.25%)

Returns from Korro Bio, Inc. Stock

-₹28,939 (-28.94%)

Dollar Impact

₹8,692 (+8.69%)

Analyst Recommendation on Korro Bio, Inc. Stock

Based on 10 analysts

BUY

90.00%

Buy

10.00%

Hold

0.00%

Sell

Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Korro Bio, Inc.. Average target price of $20.38

Korro Bio, Inc. Share Price Target

Get share price movements and forecasts by analysts on Korro Bio, Inc..

What analysts predicted

45.78%UPSIDE

Target Price

$20.38

Current Price

$11.05

Analyzed by

10 Analysts

Target

$20.38

Korro Bio, Inc. target price $20.38, a slight upside of 45.78% compared to current price of $11.05. According to 10 analysts rating.

Indian Investors' Interest in Korro Bio, Inc. Stock

Search interest for Korro Bio, Inc. Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:-4% versus previous 30 day period

Korro Bio, Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	2	2	1	1	1
Gross Profit	-1	0	0	0	2	2	1	1	0
Operating Income	-26	-21	-24	-23	-23	-25	-27	-19	-15
EBITDA	-25	-20	-23	-22	-21	-23	-25	-16	-15
Interest Expense	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	1	1	1	1	0
Income Before Tax	-25	-19	-21	-21	-21	-23	-25	-18	-49
Income Tax Expense	0	0	0	0	0	-	0	-	0
Net Income	-25	-19	-21	-20	-21	-23	-25	-18	-50
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-933.47%	-917.14%	-1765.07%	-1656.97%	-3873.22%

Korro Bio, Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	28	36	14	-	-	2	6
Gross Profit	12	35	10	-2	-3	2	2
Operating Income	-20	-27	-84	-58	-84	-91	-87
EBITDA	-17	-24	-80	-56	-80	-88	-83
Interest Expense	-	-	0	0	-	-	-
Depreciation	-	-	1	2	3	3	4
Income Before Tax	-18	-26	-84	-58	-81	-83	-116
Income Tax Expense	-	0	0	0	0	0	0
Net Income	-18	-26	-84	-58	-81	-83	-117
Net Profit Margin	-64.76%	-71.68%	-601.98%	0.00%	0.00%	-3680.36%	-1834.48%

Korro Bio, Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-19	-21	-20	-21	-23	-25	-18	-50	-19
Operating Cash Flow	-21	-14	-16	-7	-24	-19	-17	-17	-16
Investing Cash Flow	-5	-102	-12	-2	32	-11	7	14	-32
Financing Cash Flow	0	67	0	0	0	0	0	0	88
Change in Cash	-27	-49	-27	-9	8	-29	-9	-2	39

Korro Bio, Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-19	-18	-10	-21	-58	-81	-83	-117
Operating Cash Flow	-17	34	-45	-32	-53	-67	-60	-78
Investing Cash Flow	3	-18	10	-39	11	11	-123	43
Financing Cash Flow	37	142	56	115	0	187	69	0
Change in Cash	24	157	20	44	-42	131	-114	-33

Insights on Korro Bio, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 3 Years
In the last 3 years, KRRO has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 3 years, KRRO stock has moved up by 2921.8%
NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 40.2% return, outperforming this stock by 68.0%

About Korro Bio, Inc.

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia. It uses its RNA editing platform, Oligonucleotide Promoted Editing of RNA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe drug-associated anesthetics, and other pain indications. Korro Bio, Inc. has a collaboration agreement with Novo Nordisk A/S to treat cardiometabolic diseases. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Organisation	Korro Bio, Inc.
Headquarters	60 First Street, Cambridge, MA, United States, 02141
Industry	Biotechnology
CEO	Dr. Ram Aiyar MBA, Ph.D.
E-voting on shares	Click here to vote

Key Management of Korro Bio, Inc.

Name	Title
Dr. Ram Aiyar MBA, Ph.D.	CEO, President, Interim CFO, Principal Financial Officer & Director
Dr. Loic Vincent Ph.D.	Chief Scientific Officer
Mr. Todd Chappell M.B.A.	Chief Operating Officer
Ms. Stephanie Engels	Chief People Officer
Dr. Gaozhong Zhu Ph.D.	SVP of Chemistry, Manufacturing and Controls & Technical Operations
Dr. Jeffrey M. Cerio J.D., Pharm.D.	Senior VP, General Counsel & Corporate Secretary
Dr. Andrew Fraley Ph.D.	Co-Founder & Advisor
Dr. Joshua Rosenthal Ph.D.	Co-Founder & Advisor
Mr. Oliver Dolan	Senior VP of Finance & Principal Accounting Officer

FAQs

What is Korro Bio, Inc. share price today?

Korro Bio, Inc. share price today is $11.05 as on May 13, 2026 at 10:44 pm IST. Korro Bio, Inc. share today touched a day high of $11.31 and a low of $10.93.

What is the 52 week high and 52 week low for Korro Bio, Inc. share?

Korro Bio, Inc. share touched a 52 week high of $55.89 on October 16, 2025 and a 52 week low of $5.2 on December 2, 2025. Korro Bio, Inc. stock price today i.e. May 13, 2026 at 10:44 pm IST is trending at $11.05,which is 80.23% down from its 52 week high and 112.32% up from its 52 week low.

What is Korro Bio, Inc.'s market capitalisation today?

Korro Bio, Inc. market capitalisation is $0.00T as on May 13, 2026 at 10:44 pm IST.

How to invest in Korro Bio, Inc. Stock (KRRO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Korro Bio, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Korro Bio, Inc. Shares that will get you 0.1357 shares as per Korro Bio, Inc. share price of $11.05 per share as on May 13, 2026 at 10:44 pm IST.

What is the minimum amount required to buy Korro Bio, Inc. Stock (KRRO) from India?

Indian investors can start investing in Korro Bio, Inc. (KRRO) shares with as little as ₹95.705 or $1 (as of May 13, 2026 at 10:44 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Korro Bio, Inc. stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 10:44 pm IST). Based on Korro Bio, Inc. share’s latest price of $11.05 as on May 13, 2026 at 10:44 pm IST, you will get 0.9050 shares of Korro Bio, Inc.. Learn more about fractional shares .